% | $
Quotes you view appear here for quick access.

Celldex Therapeutics, Inc. Message Board

  • macrocosmonaut macrocosmonaut Dec 15, 2009 10:00 AM Flag

    CLDX - upgrade - buy

    I am upgrading CLDX from hold to speculative buy after the company has reported excellent trial results in breast cancer patients with CDX-011.

    The results of the phase II trial are really impressive and are able to lead to a change of paradigma in the treatment of breast cancer patients in future.

    I am upgrading the fair value of CLDX from 3 US$ to 8 US$ with sight on midterm view and with sight on these results.

    If the results of CDX-011 are supported by Phase III trials the new fair value of Celldex will be 28 US$.


    Do your own due dilligence.


    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • From technical point of view CLDX is developing a longterm bullish configuration.

      After tax selling in the next days - there is a high presumability that CLDX will start at 2010 a longterm bullish picture with sight on new fundamental developments and Rotarix sales of GSK.

      Collecting new shares into weakness is able to generate a good chance/risk proportion.

      It is possible that CLDX will hit 33 US$ within the next 2 years.

      The 6 months PT is at 8 US$.



      Do your own due dilligence.

4.33+0.16(+3.84%)May 27 4:00 PMEDT